Dolby Laboratories, Inc.

Dolby Laboratories, Inc.DLBEarnings & Financial Report

NYSE · Financials · Patent Owners & Lessors

Dolby Laboratories, Inc. is an American technology corporation specializing in audio noise reduction, audio encoding/compression, spatial audio, and high-dynamic-range television (HDR) imaging. Dolby licenses its technologies to consumer electronics manufacturers.

DLB Q3 FY2026 Key Financial Metrics

Revenue

$395.6M

Gross Profit

$350.9M

Operating Profit

$112.9M

Net Profit

$94.9M

Gross Margin

88.7%

Operating Margin

28.5%

Net Margin

24.0%

YoY Growth

7.1%

EPS

$0.99

Dolby Laboratories, Inc. Q3 FY2026 Financial Summary

Dolby Laboratories, Inc. reported revenue of $395.6M (up 7.1% YoY) for Q3 FY2026, with a net profit of $94.9M (up 3.4% YoY) (24.0% margin). Cost of goods sold was $44.7M, operating expenses totaled $238.0M.

Key Financial Metrics

Total Revenue$395.6M
Net Profit$94.9M
Gross Margin88.7%
Operating Margin28.5%
Report PeriodQ3 FY2026

Revenue Breakdown

Dolby Laboratories, Inc. Q3 FY2026 revenue of $395.6M breaks down across 2 segments, led by Licensing at $372.2M (94.1% of total).

SegmentRevenue% of Total
Licensing$372.2M94.1%
Products and services$23.4M5.9%

Dolby Laboratories, Inc. Revenue by Segment — Quarterly Trend

Dolby Laboratories, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Licensing and Products and services) has evolved quarter over quarter.

SegmentQ3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025
Licensing$372.2M$319.8M
Products and services$23.4M$26.9M

Dolby Laboratories, Inc. Annual Revenue by Year

Dolby Laboratories, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.3B).

YearAnnual Revenue
2025$1.3Bvs 2024
2024$1.3Bvs 2023
2023$1.3Bvs 2022

Dolby Laboratories, Inc. Quarterly Revenue & Net Profit History

Dolby Laboratories, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q3 FY2026$395.6M+7.1%$94.9M24.0%
Q2 FY2026$346.7M-2.9%$53.3M15.4%
Q1 FY2026$346.7M-2.9%$53.3M15.4%
Q4 FY2025$307.0M+0.7%$49.3M16.1%
Q3 FY2025$315.5M+9.3%$46.1M14.6%
Q2 FY2025$369.6M+1.4%$91.8M24.8%
Q1 FY2025$357.0M+13.1%$67.8M19.0%
Q4 FY2024$304.8M+4.9%$58.6M19.2%

Income Statement

Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Revenue$304.8M$357.0M$369.6M$315.5M$307.0M$346.7M$346.7M$395.6M
YoY Growth4.9%13.1%1.4%9.3%0.7%-2.9%-2.9%7.1%

Balance Sheet

Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Assets$3.11B$3.16B$3.23B$3.20B$3.23B$3.19B$3.19B$3.25B
Liabilities$623.0M$641.6M$646.0M$581.8M$595.8M$589.3M$589.3M$622.4M
Equity$2.48B$2.51B$2.57B$2.60B$2.62B$2.59B$2.60B$2.63B

Cash Flow

Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Operating CF$327.3M$106.8M$174.9M$67.7M$472.2M$54.8M$54.8M$147.3M